Research.Patient.info
Familial Adenomatous Polyposis research hub
2 indexed studies · 0 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of REC-4881 in Patients with Familial Adenomatous Polyposis (FAP)
This clinical trial is testing an experimental medicine called REC-4881 in adults with familial adenomatous polyposis (FAP). Researchers want to see if the drug is safe, how the body processes it, and whether it can help shrink or reduce the number of polyps in the bowel.
Netherlands · Germany · Spain - authorisedTherapeutic exploratory (Phase II)
Safety study for the use of Rapamycin in children with familial adenomatous polyposis - RAPA-4-FAP
This study is looking at a medicine called rapamycin for children with a condition called familial adenomatous polyposis (FAP). It mainly checks how safe the medicine is and if there are any side effects. Researchers also want to see how it affects growths in the bowel, called polyps.
France